Drug price hikes can damage company reputations, White House says amid EpiPen furor

Wednesday, August 24, 2016 - 14:01 in Mathematics & Economics

The White House on Wednesday said pharmaceutical firms risked damaging their reputations with big price hikes, but it sidestepped commenting directly on Mylan NV's decision to raise the price of its severe allergy treatment drug EpiPen.

Read the whole article on CBC: Health

More from CBC: Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net